Glenmark Pharmaceuticals Ltd.
UkraineAll drugs from this manufacturer
-
The drug is intended for the regular treatment of bronchial asthma in patients who require combination therapy (a combination of two types of active substances). It is used if standard therapy does not provide adequate symptom control or if the patient is already benefiting from combination treatment with different drugs.
Dosage form: aerosol, metered dose for inhalation
Active substance Dosage salmeterol 25 mcg per dose fluticasone 50 mcg/dose ATC: R03AK06
-
The drug is intended for the regular treatment of bronchial asthma in patients who require combination therapy (a combination of two types of active substances). It is used if standard therapy does not provide sufficient symptom control or if the patient is already benefiting from combination treatment using different drugs in separate inhalers.
Dosage form: aerosol, metered dose for inhalation
Active substance Dosage salmeterol 25 mcg per dose fluticasone 125 mcg/dose ATC: R03AK06
-
The drug is intended for the regular treatment of bronchial asthma in patients who require combination therapy (a combination of two types of active substances). It is used if standard therapy does not provide sufficient symptom control, or as a maintenance treatment if asthma has already been successfully controlled with other combination drugs.
Dosage form: aerosol, metered dose for inhalation
Active substance Dosage salmeterol 25 mcg per dose fluticasone propionate 250 mcg/dose ATC: R03AK06
-
The drug is used for the symptomatic treatment of productive cough accompanied by bronchospasm in various respiratory tract diseases.
Dosage form: tablets
Active substance Dosage salbutamol 2 mg bromhexine 8 mg guaifenesin 100 mg ATC: R05CA10
-
The drug is used to treat respiratory diseases accompanied by bronchospasm and the formation of viscous sputum that is difficult to expectorate. It is prescribed for tracheobronchitis, bronchial asthma, pulmonary emphysema, and chronic obstructive pulmonary disease.
Dosage form: syrup
Active substance Dosage salbutamol 0.2 mg/ml bromhexine 0.4 mg/ml guaifenesin 10 mg/ml menthol 0.1 mg/ml ATC: R05CA10
-
The drug is used for the local treatment of oral candidiasis and pharyngomycosis.
Dosage form: solution, oral
Active substance Dosage clotrimazole 10 mg/ml ATC: A01AB18
-
The drug is used to treat fungal diseases of the skin and mucous membranes, as well as for tinea versicolor and erythrasma.
Dosage form: solution, topical
Active substance Dosage clotrimazole 10 mg/ml ATC: D01AC01
-
The drug is used to treat fungal diseases of the skin and mucous membranes caused by dermatophytes, molds, and yeasts. It is also used for tinea versicolor, erythrasma, as well as candidal vulvitis in women and candidal balanitis in men.
Dosage form: cream
Active substance Dosage clotrimazole 10 mg/1 g ATC: D01AC01
-
The drug is used to treat fungal infections of the skin and mucous membranes, such as tinea versicolor and erythrasma.
Dosage form: powder, topical
Active substance Dosage clotrimazole 10 mg/g ATC: D01AC01
-
The drug is used to treat fungal skin infections, especially if they are accompanied by inflammation (eczema), dermatomycoses of various parts of the body, fungal infections of the feet, or dermatoses complicated by secondary infection.
Dosage form: cream
Active substance Dosage clotrimazole 10 mg beclometasone 0.25 mg ATC: D01AC20
-
The drug is used to treat infectious-inflammatory and allergic skin diseases if they are accompanied by bacterial or fungal infection.
Dosage form: cream
Active substance Dosage clotrimazole 10 mg beclometasone 0.25 mg gentamicin 1 mg ATC: D07CC04
-
The drug is used for inflammatory and allergic diseases of the external and middle ear, for ear discharge (otorrhea), as well as for ear infections caused by microorganisms sensitive to it. It is also prescribed after surgical interventions on the mastoid process.
Dosage form: drops, ear
Active substance Dosage chloramphenicol 50 mg clotrimazole 10 mg beclometasone 0.25 mg lidocaine 20 mg ATC: S02CA
-
The drug is used to treat new or recurrent pandemic infections caused by the influenza virus if other antiviral agents have not helped or were ineffective.
Dosage form: tablets, film-coated
Active substance Dosage favipiravir 200 mg ATC: J05AX27
-
The product is used for the topical treatment of common acne.
Dosage form: gel
Active substance Dosage adapalene 1 mg/g ATC: D10AD03
-
The drug is used for the topical treatment of acne vulgaris.
Dosage form: gel
Active substance Dosage adapalene 1 mg clindamycin 10 mg ATC: D10AD53
-
The drug is used for the topical treatment of common acne.
Dosage form: gel
Active substance Dosage adapalene 1 mg clindamycin 10 mg ATC: D10AD53
-
The drug is used as add-on treatment for bronchial asthma (if standard inhalers do not provide full control), for the prevention of exercise-induced asthma, and to relieve the symptoms of seasonal and perennial allergic rhinitis.
Dosage form: tablets, film-coated
Active substance Dosage montelukast 10 mg ATC: R03DC03
-
The drug is used as add-on treatment for bronchial asthma (mild to moderate forms), for the prevention of exercise-induced asthma, and to relieve symptoms of seasonal and perennial allergic rhinitis.
Dosage form: tablets, chewable
Active substance Dosage montelukast 4 mg ATC: R03DC03
-
The drug is used as an add-on treatment for bronchial asthma (mild to moderate forms), for the prevention of exercise-induced asthma, and to relieve symptoms of seasonal and perennial allergic rhinitis.
Dosage form: tablets, chewable
Active substance Dosage montelukast 5 mg ATC: R03DC03
-
The drug is used for the treatment of seasonal or perennial allergic rhinitis in adults and children from 3 years of age. It is also used for the treatment of symptoms of acute rhinosinusitis as an adjunct in sinusitis (for adults and children from 12 years of age) and for the treatment of nasal polyps in patients from 18 years of age.
Dosage form: spray, nasal, dosed, suspension
Active substance Dosage mometasone 50 mcg/dose ATC: R01AD09
-
The drug is used for the treatment of seasonal and perennial allergic rhinitis.
Dosage form: spray, nasal, dosed, suspension
Active substance Dosage mometasone 50 mcg azelastine 140 mcg ATC: R01AD
-
The drug is used for the symptomatic treatment of allergic rhinitis (including perennial) and urticaria.
Dosage form: tablets, film-coated
Active substance Dosage levocetirizine 5 mg ATC: R06AE09
-
The drug is intended to reduce the symptoms of seasonal and perennial allergic rhinitis, as well as rhinitis in people suffering from bronchial asthma.
Dosage form: tablets, film-coated
Active substance Dosage montelukast 10 mg levocetirizine 5 mg ATC: R07AX
-
The drug is used for the topical treatment of external genital and perianal condyloma, small superficial basal cell carcinomas, as well as actinic keratoses on the facial skin or scalp.
Dosage form: cream
Active substance Dosage imiquimod 5 % ATC: D06BB10
-
The shampoo is used for the treatment and prevention of fungal scalp diseases accompanied by itching and scaling. Specifically, it helps with dandruff, seborrheic dermatitis, and tinea versicolor.
Dosage form: shampoo
Active substance Dosage ketoconazole 2 g/100 ml zinc pyrithione 1 g/100 ml ATC: D01AC
-
The drug is used for the topical treatment of fungal skin infections caused by dermatophytes and yeasts. This includes tinea pedis and tinea cruris, dermatophytosis of the glabrous skin and hands, tinea barbae, candidiasis, and pityriasis versicolor.
Dosage form: cream
Active substance Dosage sertaconazole 20 mg/g ATC: D01AC14
-
The drug is used for short-term relief of inflammatory and itchy skin conditions that do not respond to weaker agents. Specifically, it is prescribed for psoriasis, erythema multiforme, discoid lupus erythematosus, and other severe dermatoses.
Dosage form: cream
Active substance Dosage clobetasol propionate 0.5 mg/g ATC: D07AD01
-
The drug is used for the treatment of seasonal allergic rhinitis.
Dosage form: spray, nasal, dosed, suspension
Active substance Dosage olopatadine 600 mcg mometasone furoate 25 mcg ATC: R01AD
-
The drug is used for the treatment of seasonal or perennial allergic rhinitis in adults and children from 3 years of age. It is also used for the treatment of nasal polyps (in adults from 18 years of age), symptoms of acute rhinosinusitis, and as an adjunct therapy for sinusitis in adults and children from 12 years of age.
Dosage form: spray, nasal, dosed, suspension
Active substance Dosage mometasone 50 mcg/dose ATC: R01AD09